Evanston, IL, United States of America

Yong Wan

This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Wan. Retrieved from https://idiyas.com/inventor/yong-wan-2s66ohc9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yong Wan - Innovator in Cancer Treatment

Introduction

Yong Wan is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented compounds. His work focuses on developing novel therapeutic strategies to combat cancer effectively.

Latest Patents

Yong Wan holds a patent for "Bifunctional compounds comprising Apcin-A and their use in the treatment of cancer." This patent describes compounds of Formula I, or their pharmaceutically acceptable salts, along with compositions that utilize these compounds. The methods outlined in the patent aim to induce Cdc20 degradation in cells, block mitotic progression, inhibit tumor proliferation, treat cancer, and re-sensitize subjects to cancer treatment with tamoxifen. He has 1 patent to his name.

Career Highlights

Yong Wan is affiliated with Northwestern University, where he conducts his research and collaborates with other experts in the field. His work has garnered attention for its potential impact on cancer therapies and treatment methodologies.

Collaborations

Yong Wan has worked alongside talented colleagues, including Zhuan Zhou and Junlong Chi. Their collaborative efforts contribute to advancing research in cancer treatment and developing innovative solutions.

Conclusion

Yong Wan's contributions to cancer treatment through his patented innovations highlight his role as a significant figure in the field. His work continues to inspire advancements in therapeutic strategies against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…